Vaccines

Thumbnail for MalarVx licenses HDT Bio’s LION technology for the development of a malaria vaccine

20 January 2025

MalarVx licenses HDT Bio’s LION technology for the development of a malaria vaccine

Thumbnail for Kenya faces medical supply crisis, endangering millions

16 January 2025

Kenya faces medical supply crisis, endangering millions

Thumbnail for WuXi Biologics sells Irish facility to Merck for US$500M

7 January 2025

WuXi Biologics sells Irish facility to Merck for US$500M

Thumbnail for Nigeria launches mpox vaccination campaign amid initial delays

13 December 2024

Nigeria launches mpox vaccination campaign amid initial delays

Thumbnail for Maze Therapeutics secures US$115M in Series D financing

9 December 2024

Maze Therapeutics secures US$115M in Series D financing

Thumbnail for Egypt unveils national strategy to boost vaccine production

9 December 2024

Egypt unveils national strategy to boost vaccine production

Thumbnail for EU Approves new liquid formulation of GSK’s Menveo

2 December 2024

EU Approves new liquid formulation of GSK’s Menveo

Thumbnail for GSK’s RSV Vaccine gains expanded approval in Japan for at-risk adults aged 50-59

22 November 2024

GSK’s RSV Vaccine gains expanded approval in Japan for at-risk adults aged 50-59

Thumbnail for South Sudan launches nationwide campaign to vaccinate over 3M children against polio

15 November 2024

South Sudan launches nationwide campaign to vaccinate over 3M children against polio

Thumbnail for Ethiopia kicks off polio vaccination campaign in five regions

14 November 2024

Ethiopia kicks off polio vaccination campaign in five regions